News
-
16
2024-12
Mainly engaged in anti-tuberculosis, antihypertensive/cardiovascular, antibiotics and vitamin derivatives and other categories of apis and intermediates -
13
2024-12
The company is a pharmaceutical enterprise integrating the production and sales of raw materials and intermediates -
10
2024-12
With high quality products and satisfactory service to cooperate with friends at home and abroad, create a better future